×
<- Back

Non-alcoholic fatty liver disease: Diagnosing, managing and cardiovascular risks

Speciality Classification
General Practice ( GP ) / Family Medicine
Location
Online
Delivery
Online
Duration
On-demand

On-demand recorded 16 Jul 2020

The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be approximately 30% of adults in Australia. NAFLD is associated with increased liver-related morbidity and mortality, and increased cardiovascular disease and cancer risk. The session covers: - the challenges of confidently diagnosing NAFLD and the tools available to assist - evidence-based approaches to managing NAFLD - cardiovascular risks associated with NAFLD and the specific management.

Learning outcomes

  • Discuss the challenges of confidently diagnosing non-alcoholic fatty liver disease and the tools available to assist this process
  • Outline evidence-based approaches to managing non-alcoholic fatty liver disease
  • Discuss the cardiovascular risks associated with non-alcoholic fatty liver disease and the specific management

This event attracts 3 CPD points

Speakers

Dr Tom Zhou
Hepatologist and Gastroenterologist

Dr Paul McEniery
Interventional Cardiologist

Dr Claire Poolman
General Practitioner

Type
Delivery
Title
Non-alcoholic fatty liver disease: Diagnosing, managing and cardiovascular risks
Interest Areas / Topics Covered
Community and Primary Health Care
Location
Provider Type
Non Profit Organisation
Duration
On-demand
CPD Points
3
Price
Free
Location
Online
105 Views
Price:
Free
Similar Listings
HealthcareLink